Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sivelestat in Acute Lung Injury with SIRS
NCT00219375Phase 4Completed
- Sponsor
- Ono Pharmaceutical
- Start
- Jun 2004
- Primary completion
- Jul 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of sivelestat in acute lung injury (ALI) (3 arms), sponsored by Ono Pharmaceutical. Primary endpoint: Ventilator Free Days at 28 days. Started Jun 2004; status: completed.
02
Drugs
sivelestat
03
Conditions
acute lung injury (ALI)
Beyond the preview
Go deeper on NCT00219375.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00219375.